CoreAge Rx publishes a sermorelin starting figure of $99 per month. ReadyRx publishes separate injection and ODT treatment pages, but our retrieved material did not establish a reliable complete current price. That leaves a quote to obtain before any honest cost ranking is possible.
CoreAge Rx receives featured commercial placement on this site. This comparison uses public information checked on September 20, 2026; we did not purchase treatment or test either service. It identifies practical differences without claiming that one provider’s preparation is clinically superior.
CoreAge Rx has a visible starting figure; ReadyRx needs a confirmed current quote. Compare the exact route, pharmacy, and refill arrangement alongside price.
An unknown price should remain unknown
A blank or incomplete price in retrieved page text is not evidence that a service is expensive, free, or unavailable. It is simply a limitation of what we could verify. Ask ReadyRx for the current product-specific total, supply period, and renewal charge rather than substituting a search snippet or another treatment's price.
For CoreAge Rx, confirm the term and services associated with the advertised starting rate. Use one comparison period and record all required charges. The cost guide makes it easier to distinguish missing information from an actual price difference.
Choose the product before comparing convenience
ReadyRx has separate pages for injection and orally disintegrating tablet treatment. The reviewed CoreAge Rx information describes an injection. If a reader prefers a tablet, that preference should lead to questions about the exact formulation and evidence, not an assumption of identical results without needles.
Ask whether the proposed product contains additional ingredients and what instructions apply. The tablet comparison covers route-specific evidence, while the vial-label article explains what to confirm for an injectable prescription. Do not convert between routes using label strength alone.
Ask how a refill is approved and interrupted
ReadyRx's public treatment material describes recurring fulfillment and options to pause or cancel. Confirm the cutoff, the next charge date, and whether a request has been acknowledged before assuming a shipment has stopped. Obtain the corresponding sermorelin-specific terms from CoreAge Rx.
Also ask what clinical review occurs at renewal. A refill schedule and a medical reassessment serve different purposes. If there is no meaningful benefit or a new concern, the clinician should be able to reconsider the plan before the next shipment. Our not-working guide helps prepare that conversation.
Pharmacy and shipping claims need concrete details
For either company, identify the dispensing pharmacy and obtain storage instructions for the exact preparation. A statement that a pharmacy is registered or regulated is not FDA approval of a compounded medicine. Ask whom to contact about a delayed shipment and whether support can route a product question to the pharmacist.
The ReadyRx review and CoreAge Rx review give the fuller service context. Compare the written answers alongside the quote. We have not tested delivery times, temperature control, clinical response times, or medication quality for either service.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- ReadyRx: SermorelinProvider primary source · Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
- CoreAge Rx: Sermorelin product pageProvider primary source · Live product page; starting price is not a verified checkout total.
- ReadyRx: Sermorelin ODTProvider primary source · Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
- FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
- FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
- FDA: Risks of compounded drugsUS regulator · Explains lack of FDA approval and the risks of poor-quality compounded preparations.
- FDA: Safe drug use after a natural disasterUS regulator · General temperature-exposure guidance. Does not establish a sermorelin stability window or injectable reconstitution method.